Tourmaline Bio Current Ratio 2020-2025 | TRML

Tourmaline Bio current ratio from 2020 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Tourmaline Bio Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.26B $0.01B 33.87
2024-12-31 $0.27B $0.01B 30.18
2024-09-30 $0.29B $0.01B 40.33
2024-06-30 $0.30B $0.01B 46.87
2024-03-31 $0.30B $0.01B 62.17
2023-12-31 $0.21B $0.01B 41.76
2023-09-30 $0.15B $0.01B 18.64
2023-06-30 $0.16B $0.01B 15.41
2023-03-31 $0.17B $0.01B 16.59
2022-12-31 $0.01B $0.00B 6.10
2022-09-30 $0.20B $0.01B 21.61
2022-06-30 $0.21B $0.01B 28.92
2022-03-31 $0.23B $0.01B 28.32
2021-12-31 $0.25B $0.01B 30.86
2021-09-30 $0.26B $0.01B 51.83
2021-06-30 $0.27B $0.01B 58.03
2021-03-31 $0.14B $0.00B 39.88
2020-12-31 $0.15B $0.00B 44.29
2020-09-30 $0.00B 0.00
2020-06-30 $0.00B 0.00
2020-03-31 $0.00B 0.00
2019-12-31 $0.04B $0.00B 17.81
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.478B $0.000B
Tourmaline Bio Inc. is a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune diseases. The company's lead program includes TOUR006. Tourmaline Bio Inc., formerly known as Talaris Therapeutics Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.846B 28.83
Zoetis (ZTS) United States $66.795B 24.92
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
Daiichi Sankyo, - (DSNKY) Japan $45.540B 23.34
BeOne Medicines - (ONC) Cayman Islands $31.822B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $20.520B 0.00
Merck (MKKGY) Germany $16.743B 12.27
Shionogi (SGIOY) Japan $14.360B 14.39
United Therapeutics (UTHR) United States $13.412B 11.86
Neurocrine Biosciences (NBIX) United States $13.272B 45.46
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.752B 63.02
Madrigal Pharmaceuticals (MDGL) United States $7.743B 0.00
Stevanato Group S.p.A (STVN) Italy $7.719B 47.20
Grifols, S.A (GRFS) Spain $6.910B 0.00
Ionis Pharmaceuticals (IONS) United States $6.712B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.417B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.583B 13.97
NewAmsterdam Pharma (NAMS) Netherlands $2.468B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.132B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.820B 0.00
Ocular Therapeutix (OCUL) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.802B 0.00
Endo (NDOI) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Harrow (HROW) United States $1.326B 0.00
Guardian Pharmacy Services (GRDN) United States $1.317B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Enliven Therapeutics (ELVN) United States $1.145B 0.00
Ardelyx (ARDX) United States $1.081B 0.00
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $1.037B 5.59
ProKidney (PROK) United States $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Verve Therapeutics (VERV) United States $0.976B 0.00
Xeris Biopharma Holdings (XERS) United States $0.818B 0.00
KalVista Pharmaceuticals (KALV) United States $0.800B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.738B 0.00
Zevra Therapeutics (ZVRA) United States $0.692B 0.00
Xencor (XNCR) United States $0.646B 0.00
Relay Therapeutics (RLAY) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Theravance Biopharma (TBPH) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.570B 12.40
Organogenesis (ORGO) United States $0.553B 0.00
Bioventus (BVS) United States $0.533B 13.52
Siga Technologies (SIGA) United States $0.479B 10.00
Aquestive Therapeutics (AQST) United States $0.434B 0.00
Savara (SVRA) United States $0.404B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Altimmune (ALT) United States $0.328B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
AleAnna (ANNA) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.88
Nanobiotix S.A (NBTX) France $0.250B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Liminatus Pharma (LIMN) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 19.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Vivani Medical (VANI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Rafael Holdings (RFL) United States $0.080B 0.00
Metagenomi (MGX) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Klotho Neurosciences (KLTO) United States $0.063B 0.00
Avalo Therapeutics (AVTX) United States $0.061B 0.00
Inotiv (NOTV) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 41.22
ElectroCore (ECOR) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.45
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00